Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2

Journal article

Michael S. et al, (2020), Practical Neurology

Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.

Journal article

Ramberger M. et al, (2020), Brain, 143, 1731 - 1745

Real-world prevalence of autoantibodies in epilepsy

Conference paper

McGinty RN. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 61 - 61

Intrathecal B cell activation in LGI1-antibody encephalitis

Journal article

lehmann-horn K. et al, (2019), Neurology: Neuroimmunology & Neuroinflammation.

CXCL13 LEVELS AND AUTOANTIBODY EPITOPE SPECIFICITIES IN LGI1-AUTOANTIBODY SYNDROMES

Conference paper

Michael S. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E34 - E35

CXCL13 Levels in LGI1-and CASPR2-autoantibody syndromes

Conference paper

Michael S. et al, (2019), EUROPEAN JOURNAL OF NEUROLOGY, 26, 265 - 265

Immunophenotyping of autoimmune epilepsy by mass cytometry

Conference paper

McGinty RN. et al, (2019), *JournalName*, 26, 135 - 135

Seronegative antibody-mediated neurology after immune checkpoint inhibitors

Journal article

Wilson R. et al, (2018), Annals of Clinical and Translational Neurology, 5, 640 - 645

A practical guide to the use of anti-epileptic drugs by neurosurgeons

Journal article

Afshari FT. et al, (2017), British Journal of Neurosurgery, 31, 551 - 556

Severe but reversible neuropathy and encephalopathy due to vitamin E deficiency

Journal article

Wysota B. et al, (2017), Clinical Neurology and Neurosurgery, 160, 19 - 20